Likes Subject
SEC filing 8-k > On August 30, 2022, crudeoil24 08/31/22 8:40 AM
-- Interim Phase 1/2 results for zilovertamab TechandBio 08/24/22 8:11 AM
64k on the bid. TechandBio 08/22/22 3:51 PM
Oncternal therapeutics: Zilovertamab Phase 3 study Ror1 ZILO-301 TechandBio 08/22/22 8:06 AM
Expected Upcoming Milestones crudeoil24 08/21/22 11:04 PM
That 15.00 PT will be broken on crudeoil24 08/19/22 3:42 PM
Analyst update for ONCT TechandBio 08/19/22 2:15 PM
Phase 3 with ABBV that makes their blockbuster TechandBio 08/18/22 6:56 PM
Positive fundamental & technical catalysts taking ONCT share crudeoil24 08/18/22 8:05 AM
Building higher support level broke the 50 day TechandBio 08/18/22 6:06 AM
Anticipated Pipeline Milestones TechandBio 08/17/22 5:59 PM
Oncternal Therapeutics Provides Business Update. TechandBio 08/17/22 5:53 PM
Imbruvica (ibrutinib) Pharmacyclics (AbbVie) and Janssen (Johnson & J TechandBio 08/17/22 9:26 AM
Outperform rating. Analyst Oppenheimer Hartaj Singh has TechandBio 08/16/22 2:45 PM
Added again this one looks ready to go. TechandBio 08/16/22 9:46 AM
Oncternal Therapeutics Drives Complete Responders with First in TechandBio 08/16/22 7:38 AM
slapped the ask here a little. Let's go, TechandBio 08/15/22 11:23 AM
VIDEO ZILO-301: Phase III study of zilovertamab + TechandBio 08/13/22 1:10 PM
10x-20x Potential in the cards DD TechandBio 08/12/22 9:44 PM
Took a starter here. TechandBio 08/12/22 9:35 PM
H.C. Wainwright Thinks Oncternal Therapeutics’ Stock is Going $$ Golden Cross $$ 05/31/22 7:36 AM
It moved finally I expect more to come robertus 05/29/22 3:53 PM
Good to go now Triple nickle 05/27/22 10:11 AM
I’m on it Triple nickle 05/27/22 9:46 AM
https://www.benzinga.com/wiim/22/01/24894238/oncternal-therapeutics-shares- zetatauri 01/05/22 7:51 AM
https://seekingalpha.com/article/4447087-oncternal-therapeutics-inc-onct-ce zetatauri 08/09/21 9:10 AM
Of course. My question was from last November. KingOfSwing...Trading 07/21/21 6:50 PM
Very much so. I saw your post zetatauri 07/21/21 6:40 PM
ONCT board inactive 4gh1rx 07/21/21 5:36 PM
* * $ONCT Video Chart 12-10-2020 * * ClayTrader 12/10/20 6:04 PM
Thanks for the trip to the ATM, ONCT. KingOfSwing...Trading 12/09/20 10:26 AM
* * $ONCT Video Chart 12-07-2020 * * ClayTrader 12/07/20 4:17 PM
Lol. And the reason for that ipo_dude 12/07/20 1:57 PM
What do you see as the catalyst? KingOfSwing...Trading 11/23/20 8:57 AM
Consolidating and then we blast off!$$$ Jess070283 11/10/20 11:44 AM
Carl Icahn takes stake. Wow $8 today Biggeoff 11/10/20 6:57 AM
* * $ONCT Video Chart 11-09-2020 * * ClayTrader 11/09/20 4:49 PM
It hit $8.32 yesterday after-hours. Luna Tic 11/09/20 1:51 PM
$10+ Just beginning!$$$$ Jess070283 11/09/20 11:11 AM
So I read, this could run very, very dinogreeves 11/08/20 12:06 PM
This is either running for an offering, or dinogreeves 11/08/20 11:13 AM
Some say, sympathy play of AP*VO, I say dinogreeves 11/07/20 12:16 PM
88.2M cap @ 4$ dinogreeves 11/07/20 12:14 PM
ONCT on fire all next week. Only if dinogreeves 11/07/20 12:07 PM
With my years of experience, the perfect formula Luna Tic 11/07/20 12:06 PM
ONCT GM Luna, I won't lie about it mdstocks 11/07/20 11:48 AM
Yep! I only own a few hundred shares, Luna Tic 11/07/20 8:49 AM
ONCT Luna,funny you should ask....yep sure do....I'm a mdstocks 11/06/20 11:48 PM
Nice move after hours Luna Tic 11/06/20 10:03 PM
Still own ONTC !!!!!!!!!!!!!!!!! Luna Tic 11/06/20 10:00 PM
Likes Subject

crudeoil24
08/31/22 8:40 AM
TechandBio
08/22/22 3:51 PM
crudeoil24
08/21/22 11:04 PM
crudeoil24
08/19/22 3:42 PM
TechandBio
08/19/22 2:15 PM
TechandBio
08/17/22 5:59 PM
TechandBio
08/16/22 9:46 AM
TechandBio
08/15/22 11:23 AM
TechandBio
08/12/22 9:44 PM
TechandBio
08/12/22 9:35 PM
robertus
05/29/22 3:53 PM
Triple nickle
05/27/22 10:11 AM
Triple nickle
05/27/22 9:46 AM
KingOfSwing...Trading
07/21/21 6:50 PM
zetatauri
07/21/21 6:40 PM
4gh1rx
07/21/21 5:36 PM
ClayTrader
12/10/20 6:04 PM
KingOfSwing...Trading
12/09/20 10:26 AM
ClayTrader
12/07/20 4:17 PM
ipo_dude
12/07/20 1:57 PM
KingOfSwing...Trading
11/23/20 8:57 AM
Jess070283
11/10/20 11:44 AM
Biggeoff
11/10/20 6:57 AM
ClayTrader
11/09/20 4:49 PM
Luna Tic
11/09/20 1:51 PM
Jess070283
11/09/20 11:11 AM
dinogreeves
11/08/20 12:06 PM
dinogreeves
11/08/20 11:13 AM
dinogreeves
11/07/20 12:16 PM
dinogreeves
11/07/20 12:14 PM
dinogreeves
11/07/20 12:07 PM
mdstocks
11/07/20 11:48 AM
Luna Tic
11/07/20 8:49 AM
Luna Tic
11/06/20 10:03 PM
Luna Tic
11/06/20 10:00 PM

ONCTERNAL THERAPEUTICS, INC (ONCT)

Followers
71
Posters
240
Posts (Today)
0
Posts (Total)
1442
Created
02/25/08
Type
Free
Moderators

GTx Inc. website

 

http://finance.yahoo.com/q/ks?s=GTXI

Charts and tec stuff

 

GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules
to treat cancer, osteoporosis and bone loss, muscle wasting, and other serious medical conditions in the United States. The
company markets FARESTON tablets for the treatment of metastatic breast cancer in postmenopausal women through wholesale
drug distributors. Its product candidates in clinical development include ACAPODENE, a selective estrogen receptor modulator,
which is in pivotal Phase III clinical trials for the treatment of multiple serious side effects of androgen deprivation therapy, for
advanced prostate cancer; and for the prevention of prostate cancer in high risk men with precancerous prostate lesions called
high grade prostatic intraepithelial neoplasia (PIN). The company also develops Ostarine, a selective androgen receptor modulator,
which is in phase IIb clinical trials for the treatment of cancer cachexia; and for chronic kidney disease, and end-stage renal disease.
In addition, GTx develops Andarine for the treatment of various medical conditions relating to muscle wasting and/or bone loss;
prostarine for the treatment of benign prostatic hyperplasia; and andromustine, an anticancer product candidate for hormone refractory
prostate cancer. It has collaborations with Hybritech, Inc.; diaDexus, Inc.; MacroArray Technologies, LLC; Onconome, Inc.; and
Gen-Probe, Incorporated to develop an accurate blood or urine test to detect high grade PIN. GTx also has a research and development,
and strategic collaboration with Merck & Co., Inc. for the development of selective androgen receptor modulators. The company was
founded in 1997 and is headquartered in Memphis, Tennessee.
 

Most Liked Posts
(Last 30 Days)
New Post